DTaP-IPV/Hib vaccine
| Combination of | |
|---|---|
| DTaP vaccine | Vaccine |
| Inactivated poliovirus vaccine | Vaccine |
| Hib vaccine | Vaccine |
| Clinical data | |
| Trade names | Pentacel, Pediacel, Infanrix IPV + Hib, Pentaxim |
| AHFS/Drugs.com | Pentacel |
| Routes of administration | Intramuscular injection |
| ATC code | |
DTaP-IPV/Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus B conjugate (tetanus toxoid conjugate) vaccine.[1] It is also known as DTaP-IPV/Hib or DTaP-IPV-Hib. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type B.
A branded formulation marketed in the USA is Pentacel, manufactured by Sanofi Pasteur.[2] Pentacel is known in the UK and Canada as Pediacel. An equivalent vaccine marketed in the UK and Canada by GlaxoSmithKline is Infanrix IPV + Hib. This is a two-part vaccine. The DTaP-IPV component is supplied as a sterile liquid, which is used to reconstitute lyophilized (freeze-dried) Hib vaccine.
Pentaxim is a liquid formulation marketed by Sanofi Pasteur.
References
- ^ "Diphtheria and Tetanus Toxoids, Acellular Pertussis, Poliovirus and Haemophilus b Conjugate Vaccine". Drugs.com. Retrieved 15 July 2018.
- ^ "Pentacel". US Food and Drug Administration. Retrieved 15 July 2018.
 | This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |